Join Now

Known Medicine Partners with Duke University to Predict Lung Cancer Response to Drug Treatments

Collaboration aims to capture patient-to-patient variability to determine the best treatment for every cancer

Posted in BioUtah News | Tagged | Leave a comment

KNOWN MEDICINE RAISES $7.2 MILLION SEED ROUND TO ADVANCE DATA FIRST APPROACH TO ORGANOID TECHNOLOGY

Known Medicine today announced the closure of its seed round of funding in the amount of $7.2 million led by Caffeinated Capital, with participation from Khosla Ventures, Cota Capital, Kickstart, Forward VC, OATV, Y Combinator and noted angel investors Chris Gibson, CEO & Co-Founder at Recursion Pharmaceuticals, Nish Bhat, previously Co-Founder at Color Genomics, and others.

Posted in BioUtah News | Tagged | Leave a comment